These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 29456214

  • 1. Outcome of renal transplant recipients with cytomegalovirus and BK polyomavirus co-infection nephropathy.
    Kaul A, Kumar S, Bhaduaria D, Agrawal V, Sharma RK, Prasad N, Gupta A, Kumar R.
    Saudi J Kidney Dis Transpl; 2018; 29(1):101-106. PubMed ID: 29456214
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Viral infections directly involved in kidney allograft function.
    Masutani K.
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():31-37. PubMed ID: 29968408
    [Abstract] [Full Text] [Related]

  • 4. Viral Origin, Clinical Course, and Renal Outcomes in Patients With BK Virus Infection After Living-Donor Renal Transplantation.
    Schwarz A, Linnenweber-Held S, Heim A, Framke T, Haller H, Schmitt C.
    Transplantation; 2016 Apr; 100(4):844-53. PubMed ID: 26720302
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Correlation of BK Virus Neutralizing Serostatus With the Incidence of BK Viremia in Kidney Transplant Recipients.
    Abend JR, Changala M, Sathe A, Casey F, Kistler A, Chandran S, Howard A, Wojciechowski D.
    Transplantation; 2017 Jun; 101(6):1495-1505. PubMed ID: 27854236
    [Abstract] [Full Text] [Related]

  • 8. BK Virus in Renal Transplant Patients Using Alemtuzumab for Induction Immunosuppression.
    Korneffel K, Gehring B, Rospert D, Rees M, Ortiz J.
    Exp Clin Transplant; 2020 Oct; 18(5):557-563. PubMed ID: 31324134
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Elimination of BK viremia in renal transplant recipients by optimization of immunosuppressive medications without precipitating acute rejection.
    Jha A, Ahmed W, Pakkyara A, Shaheen F, Al Salmi I.
    Saudi J Kidney Dis Transpl; 2018 Oct; 29(5):1073-1081. PubMed ID: 30381503
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differential Diagnosis of Interstitial Allograft Rejection and BKV Nephropathy by T-cell Receptor Sequencing.
    Stervbo U, Nienen M, Hecht J, Viebahn R, Amann K, Westhoff TH, Babel N.
    Transplantation; 2020 Apr; 104(4):e107-e108. PubMed ID: 32224816
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevalence and Risk Factors of BK Viremia and Clinical Impact of BK Virus Surveillance on Outcomes in Kidney Transplant Recipients: A Single-Center Cross-Sectional Study.
    Ji J, Feng S, Jiang Y, Wang W, Zhang X.
    Exp Clin Transplant; 2019 Dec; 17(6):727-731. PubMed ID: 30995893
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Temporal serum creatinine increase and exacerbation of tubulointerstitial inflammation during the first two months in resolving polyomavirus BK nephropathy.
    Masutani K, Tsuchimoto A, Matsukuma Y, Kurihara K, Nishiki T, Kitada H, Tanaka M, Kitazono T, Tsuruya K.
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():45-50. PubMed ID: 26031586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.